Clinical Trials Directory

Trials / Completed

CompletedNCT01350895

Clinical and Biochemical Presentation of Polycystic Ovary Syndrome in Different Age Group

Status
Completed
Phase
Study type
Observational
Enrollment
781 (actual)
Sponsor
Taipei Medical University WanFang Hospital · Academic / Other
Sex
Female
Age
18 Years – 46 Years
Healthy volunteers
Accepted

Summary

To study the clinical and biochemical characteristics women with polycystic ovary syndrome (PCOS) in different aged groups.

Detailed description

Polycystic ovarian syndrome (PCOS) is the most frequent endocrine disorder of reproductive age women, affecting an estimated 9-18% of all women in this age group. To diagnose of PCOS in early life is especially important because it is now thought to increase metabolic and cardiovascular risks. Investigating PCOS is crucial as it is now considered to increase metabolic and cardiovascular risk, thereby impacting the health of women to a much greater extent than previously thought. We are plan using retrospective analysis to evaluate the clinical and biochemical presentation of PCOS in different aged groups.

Conditions

Timeline

Start date
2011-02-01
Primary completion
2012-04-01
Completion
2012-04-01
First posted
2011-05-10
Last updated
2013-11-06

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT01350895. Inclusion in this directory is not an endorsement.

Clinical and Biochemical Presentation of Polycystic Ovary Syndrome in Different Age Group (NCT01350895) · Clinical Trials Directory